fluorobenzenes has been researched along with Carcinoma, Ductal, Breast in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goyal, S; Haffty, BG; Taunk, NK | 1 |
1 other study(ies) available for fluorobenzenes and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Radiation recall 5 years after whole-breast irradiation for early-stage breast cancer secondary to initiation of rosuvastatin and amlodipine.
Topics: Amlodipine; Anti-Bacterial Agents; Antihypertensive Agents; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cellulitis; Diagnosis, Differential; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mastectomy, Segmental; Middle Aged; Neoplasm Staging; Pyrimidines; Radiodermatitis; Radiotherapy, Adjuvant; Rosuvastatin Calcium; Sulfonamides; Time Factors | 2011 |